Internal Medicine, Rheumatology · Albuquerque, NM
NPI
1568438752
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1617 University Blvd NE
Albuquerque, NM, 87102
Phone (505) 341-4148
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
171,910 services
Medicare patients, 2024
408
Average age 72
Drug cost, 2024
$4.4M
5,891 prescriptions
Company payments, 2025
$1,546
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Leroy A Pacheco was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 66,000 times for 25 patients. In total Leroy A Pacheco billed 171,910 services in 52 codes, and Medicare paid $1.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 66,000 | 25 | $3.51 | $232K |
| J3262 Injection, tocilizumab, 1 mg | Office | 50,262 | 17 | $4.70 | $236K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 13,300 | 25 | $9.04 | $120K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 13,050 | 39 | $33.28 | $434K |
| J9312 Injection, rituximab, 10 mg | Office | 4,750 | 20 | $60.10 | $285K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 3,701 | 19 | $24.90 | $92K |
| Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 2,800 | 14 | $23.11 | $65K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,565 | 27 | $0.10 | $268 |
| J0897 Injection, denosumab, 1 mg | Office | 1,740 | 21 | $20.06 | $35K |
| 99213 Office E&M - Established | Office | 574 | 293 | $60.63 | $35K |
| 96372 Injection Administration | Office | 335 | 28 | $10.21 | $3,422 |
| 96415 Chemotherapy Administration | Office | 321 | 61 | $20.02 | $6,427 |
| 96413 Chemotherapy Administration | Office | 308 | 75 | $91.51 | $28K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 306 | 24 | $0.76 | $232 |
| 96365 Intravenous Infusion, Hydration | Office | 281 | 71 | $45.90 | $13K |
By year: 2022 $1.3M for 110,123 services; 2023 $1.3M for 119,936 services; 2024 $1.8M for 171,910 services.
Medicare prescription drug claims, 2024
In 2024, the drug Leroy A Pacheco prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 688 prescriptions and refills. In total Leroy A Pacheco wrote 5,891 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 688 | 1,192 | 149 | $16K |
| Prednisone Generic | 653 | 842 | 153 | $5,054 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 414 | 414 | 72 | $15K |
| Hydroxychloroquine Sulfate Generic | 404 | 773 | 100 | $12K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 270 | 270 | 41 | $11K |
| Tramadol Hcl Generic | 199 | 206 | 49 | $2,694 |
| Gabapentin Generic | 169 | 227 | 36 | $3,099 |
| Oxycodone Hcl Generic | 135 | 135 | 18 | $3,429 |
| Baclofen Generic | 124 | 158 | 25 | $1,419 |
| Leflunomide Generic | 123 | 225 | 32 | $5,472 |
| Leucovorin Calcium Generic | 119 | 189 | 25 | $1,265 |
| Duloxetine Hcl Generic | 114 | 179 | 24 | $2,021 |
| Morphine Sulfate Er Morphine Sulfate | 106 | 106 | 19 | $3,046 |
| Alendronate Sodium Generic | 104 | 194 | 27 | $984 |
| Allopurinol Generic | 104 | 182 | 20 | $1,138 |
Brand drugs: - claims; generic drugs: 5,135 claims; opioid claims: 1,211.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Leroy A Pacheco $1,546 ($1,546 in general payments such as food, travel and fees) from 23 companies. The largest payer was Abbvie Inc. with $309.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 30 | $309 |
| UCB, Inc. UCB.BR | 8 | $287 |
| Genentech USA, Inc. ROG.SW | 24 | $190 |
| Janssen Biotech, Inc. JNJ | 3 | $131 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $98.25 |
| Amgen Inc. AMGN | 4 | $76.92 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $73.32 |
| GlaxoSmithKline, LLC. GSK | 3 | $68.57 |
| Sobi, Inc SOBI.ST | 2 | $54.99 |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $47.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.